CSIMarket
 


Johnson and Johnson  (JNJ)
Other Ticker:  
 
 

JNJ's EPS from Cont. Operations Growth by Quarter and Year

Johnson And Johnson's EPS from Cont. Operations results by quarter and year




JNJ EPS from Cont. Operations (in $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter January - 0.66 1.52 1.13
III Quarter October - 1.35 0.67 1.47
II Quarter July - 1.38 2.11 1.47
I Quarter April 2.35 2.20 1.41 1.63
FY   2.35 5.59 5.71 5.70



JNJ EPS from Cont. Operations first quarter 2021 Y/Y Growth Comment
Johnson and Johnson reported EPS from Cont. Operations growth of 6.82% year on year in the first quarter, to $ 2.35 , this is lower than Johnson And Johnson's recent average EPS from Cont. Operations improvement of 26.01%.

Looking into first quarter results within Major Pharmaceutical Preparations industry 14 other companies have achieved higher EPS from Cont. Operations growth. While Johnson And Johnson' s EPS from Cont. Operations increase of 6.82% ranks overall at the positon no. 826 in the first quarter.




JNJ EPS from Cont. Operations ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter January - -56.58 % 34.51 % -
III Quarter October - 101.49 % -54.42 % 5 %
II Quarter July - -34.6 % 43.54 % 3.52 %
I Quarter April 6.82 % 56.03 % -13.5 % 0 %
FY   - -2.1 % 0.18 % 1139.13 %

Financial Statements
Johnson And Johnson's first quarter 2021 EPS from Cont. Operations $ 2.35 JNJ's Income Statement
Johnson And Johnson's first quarter 2020 EPS from Cont. Operations $ 2.20 Quarterly JNJ's Income Statement
New: More JNJ's historic EPS from Cont. Operations Growth >>


JNJ EPS from Cont. Operations (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter January - -51.11 % 126.87 % -23.13 %
III Quarter October - -2.17 % -68.25 % 0 %
II Quarter July - -37.27 % 49.65 % -9.82 %
I Quarter April 256.06 % 44.74 % 24.78 % -
FY (Year on Year)   - -2.1 % 0.18 % 1139.13 %




EPS from Cont. Operations first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #15
Healthcare Sector #58
Overall #826

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
1387.5 % 26.01 % -100 %
(Dec. 30. 2012)   (Jan 01 2012)
EPS from Cont. Operations first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #15
Healthcare Sector #58
Overall #826
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
1387.5 % 26.01 % -100 %
(Dec. 30. 2012)   (Jan 01 2012)

EPS from Cont. Operations by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Johnson And Johnson's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
1687.5 % 32.28 % -100 %
(March 31, 2012)  


JNJ's I. Quarter Q/Q EPS from Cont. Operations Comment
Johnson and Johnson achieved in the I. Quarter 2021 above company average sequential EPS from Cont. Operations doubling of 256.06%, to $ 2.35 , from $0.66 in the forth quarter.
Major Pharmaceutical Preparations company is going from strength to strength, not just claiming higher then average growth, and additionally accelerating speed, Isaac  Evans, Major Pharmaceutical Preparations industry observer mentioned.

Within Major Pharmaceutical Preparations industry Johnson and Johnson achieved highest sequential EPS from Cont. Operations growth. While Johnson And Johnson's EPS from Cont. Operations growth quarter on quarter, overall rank is 21.


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #2
Overall #21
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #2
Overall #21
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
1687.5 % 32.28 % -100 %
(March 31, 2012)  


JNJ's I. Quarter Q/Q EPS from Cont. Operations Comment
Johnson and Johnson achieved in the I. Quarter 2021 above company average sequential EPS from Cont. Operations doubling of 256.06%, to $ 2.35 , from $0.66 in the forth quarter.
JNJ is undergoing a remarkable growth, not only claiming above average gain, but also increasing pace.

Within Major Pharmaceutical Preparations industry Johnson and Johnson achieved highest sequential EPS from Cont. Operations growth. While Johnson And Johnson's EPS from Cont. Operations growth quarter on quarter, overall rank is 21.


Johnson And Johnson's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Apr 04 2021)
12 Months Ending
(Jan 03 2021)
12 Months Ending
(Sep 27 2020)
12 Months Ending
(Jun 28 2020)
12 Months Ending
(Mar 29 2020)
Cumulative EPS from Cont. Operations 12 Months Ending $ 5.74 $ 5.59 $ 6.45 $ 5.77 $ 6.50
Y / Y EPS from Cont. Operations Growth (TTM) -11.74 % -2.16 % 21.31 % -5.66 % 18.68 %
Year on Year EPS from Cont. Operations Growth Overall Ranking # 390 # 427 # 158 # 861 # 468
Seqeuential EPS from Cont. Operations Change (TTM) 2.68 % -13.38 % 11.78 % -11.22 % 13.83 %
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # 391 # 848 # 159 # 201 # 280




Cumulative EPS from Cont. Operations growth Comment
Johnson And Johnson's cumulative 12 months EPS from Cont. Operations continue to fall, but on the faster rate at -11.74% year on year, at Apr 04 2021 compare to the -2.16% decrease at Jan 03 2021. If the Johnson And Johnson's fiscal year would end at Apr 04 2021, annual EPS from Cont. Operations would be $6 .

Within the Healthcare sector 30 other companies have achieved higher trailing twelve month EPS from Cont. Operations growth. While Total ranking has impoved so far to 390, from total ranking in previous quarter at 427.

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
882.92 %
15.38 %
-92.23 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 5
Healthcare Sector # 31
Overall # 390

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
1139.38 %
72.84 %
-92.48 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 5
Sector # 28
S&P 500 # 391
Cumulative EPS from Cont. Operations growth Comment
Johnson And Johnson's cumulative 12 months EPS from Cont. Operations continue to fall, but on the faster rate at -11.74% year on year, at Apr 04 2021 compare to the -2.16% decrease at Jan 03 2021. If the Johnson And Johnson's fiscal year would end at Apr 04 2021, annual EPS from Cont. Operations would be $6 .

Within the Healthcare sector 30 other companies have achieved higher trailing twelve month EPS from Cont. Operations growth. While Total ranking has impoved so far to 390, from total ranking in previous quarter at 427.

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
882.92 %
15.38 %
-92.23 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 5
Healthcare Sector # 31
Overall # 390

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
1139.38 %
72.84 %
-92.48 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 5
Sector # 28
S&P 500 # 391




Other EPS from Cont. Operations Growth
Major Pharmaceutical Preparations Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
JNJ's EPS from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for JNJ's Competitors
EPS from Cont. Operations Growth for Johnson And Johnson's Suppliers
EPS from Cont. Operations Growth for JNJ's Customers

You may also want to know
JNJ's Annual Growth Rates JNJ's Profitability Ratios JNJ's Asset Turnover Ratio JNJ's Dividend Growth
JNJ's Roe JNJ's Valuation Ratios JNJ's Financial Strength Ratios JNJ's Dividend Payout Ratio
JNJ's Roa JNJ's Inventory Turnover Ratio JNJ's Growth Rates JNJ's Dividend Comparisons



Companies with similar EPS from Cont. Operations fall for the quarter ending Apr 04 2021 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Apr 04 2021


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CBFV's Profile

Stock Price

CBFV's Financials

Business Description

Fundamentals

Charts & Quotes

CBFV's News

Suppliers

CBFV's Competitors

Customers & Markets

Economic Indicators

CBFV's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071